Margaret Koziel - 10 Dec 2021 Form 4 Insider Report for Axcella Health Inc.

Role
Chief Medical Officer
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
13 Dec 2021, 16:56:43 UTC
Previous filing
13 Dec 2021
Next filing
10 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 10 Dec 2021 Common Stock 75,000 $2.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on December 10, 2022, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.